Differential expression of PTEN in normal adult rat brain and upregulation of PTEN and p-Akt in the ischemic cerebral cortex

Anatomical Record

Volumn 292, Issue 4, 2009, Pages 498-512

  Cai, Qi Yan ^a   Chen, Xing Shu ^a   Zhong, Shan Chuan ^a   Luo, Xue ^a   Yao, Zhong Xiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adult rat; Global ischemia; Immunoreactivity; P Akt; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ADULT ANIMAL; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN ISCHEMIA; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NERVE CELL PLASTICITY; NONHUMAN; OLFACTORY NUCLEUS; PONS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PURKINJE CELL; RAT; THALAMUS; UPREGULATION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BRAIN; BRAIN ISCHEMIA; BRAIN MAPPING; CELL SURVIVAL; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; NEURONAL PLASTICITY; NEURONS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

RATTUS;

EID: 65549135855     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20834     Document Type: Article

References (65)

1. Andjelkovic M, Alessi DR, Meier R, Fernandez A, Lamb NJC, Frech M, Cron P, Cohen P, Lucocq JM, Hemmings BA. 1997. Role of translocation in the activation and function of protein kinase B. J Biol Chem 272:31515-31524.
2. Backman SA, Stambolic V, Suzuki A, Haight J, Elia A, Pretorius J, Tsao MS, Shannon P, Bolon B, Ivy GO, Mak TW. 2001. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 29:396-403.
3. Bradford MM. 1976. A rapid and sensitive method for the quantification of micrograms quantities of proteins utilizing the principle of protein dye binding. Anal Biochem 72:248-254.
4. Cahill MA, Janknecht R, Nordheim A. 1996. Signalling pathways: jack of all cascades. Curr Biol 6:16-19.
5. Cantley LC, Neel BG. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/ AKT pathway. Proc Natl Acad Sci 96:4240-4245.
6. Chang N, El-Hayek YH, Gomez E, Wan Q. 2007. Phosphatase PTEN in neuronal injury and brain disorders. Trends Neurosci 30:581-586.
7. Choi JS, Park HJ, Kim HY, Kim SY, Lee JE, Choi YS, Chun MH, Chung JW, Lee MY. 2005. Phosphorylation of PTEN and Akt in astrocytes of the rat hippocampus following transient forebrain ischemia. Cell Tissue Res 319:359-366.
8. Choy MS, Bay BH, Cheng HC, Cheung NS. 2006. PTEN is recruited to specific microdomains of the plasma membrane during lactacystin-induced neuronal apoptosis. Neurosci Lett 405:120-125.
9. Datta SR, Brunet A, Greenberg ME. 1999. Cellular survival: A play in three Akts. Genes Dev 13:2905-2927.
10. Fraser MM, Zhu XY, Kwon CH, Uhlmann EJ, Gutmann DH, Baker SJ. 2004. Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res 64:7773-7779.
11. Gary DS, Mattson MP. 2002. PTEN regulates Akt kinase activity in hippocampal neurons and increases their sensitivity to glutamate and apoptosis. Neuromolecular Med 2:261-269.
12. Gimm O, Attie-Bitach T, Lees JA, Vekemans M, Eng C. 2000. Expression of the PTEN tumour suppressor protein during human development. Hum Mol Genet 9:1633-1639.
13. Groszer M, Erickson R, Scripture-Adams DD, Dougherty JD, Belle JH, Zack JA, Geschwind DH, Liu X, Kornblum HI, Wu H. 2006. PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. Proc Natl Acad Sci 103:111-116.
14. Groszer M, Erickson R, Scripture-Adams DD, Lesche R, Trumpp A, Zack JA, Kornblum HI, Liu X, Wu H. 2001. Negative regulation of neural stem/ progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294:2186-2189.
15. Gu J, Tamura M, Yamada KM. 1998. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 143:1375-1383.
16. Hillebrand JJ, de Wied D, Adan RA. 2002. Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides 23:2283-2306.
17. Ito Y, Goto K, Kondo H. 1995. Localization of mRNA for phosphatidylinositol 3-kinase in brain of developing and mature rats. Mol Brain Res 34:149-153.
18. Jaworski J, Spangler S, Seeburg DP, Hoogenraad CC, Sheng M. 2005. Control of dendritic arborization by the phosphoinositide-3′- kinase-Akt-mammalian target of rapamycin pathway. J Neurosci 25:11300-11312.
19. Ji SP, Cleemput JC, Jiang W, Liao MX, Li L, Wan Q, Backstrom JR, Zhang X. 2006. Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse. Nat Med 12:324-329.
20. Jiang Z, Zhang Y, Chen X, Lam PY, Yang H, Xu Q, Hoi Yu AC. 2003. Activation of Erk1/2 and Akt in astrocytes under ischemia. Neurochem Res 28:831-837.
21. Kabir J, Lobo M, Zachary I. 2002. Staurosporine induces endothelial cell apoptosis via focal adhesion kinase dephosphorylation and focal adhesion disassembly independent of focal adhesion kinase proteolysis. Biochem J 367:145-155.
22. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. 1999. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20:68-100.
23. Kitagawa H, Warita H, Sasaki C, Zhang WR, Sakai K, Shiro Y, Mitsumoto Y, Mori T, Abe K. 1999. Immunoreactive Akt, PI3-K and ERK protein kinase expression in ischemic rat brain. Neurosci Lett 274:45-48.
24. Knobbe CB, Reinfenberger G. 2003. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-30-kinase/ protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Patholl 13:507-518.
25. Kremer H, Nelen M, Schepens J, Hendrik W, Padberg G. 1999. PTEN transcription in mouse development. Am J Hum Genet(-Suppl):A134.
26. Kwon CH, Zhu X, Zhang J, Knoop LL, Tharp R, Smeyne RJ, Eberhart CG, Burger PC, Baker SJ. 2001. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29:404-411.
27. Lachyankar MB, Sultana N, Schonhoff CM, Mitra P, Poluha W, Lambert S, Quesenberry PJ, Litofsky NS, Recht LD, Nabi R, Miller SJ, Ohta S, Neel BG, Ross AH. 2000. A role for nuclear PTEN in neuronal differentiation. J Neurosci 20:1404-1413.
28. Lee JH, Kim KY, Lee YK, Park SY, Kim CD, Lee WS, Rhim BY, Hong KW. 2003. Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats. J Pharmacol Exp Ther 308:896-903.
29. Li DM, Sun H. 1997. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res 57:2124-2129.
30. Li DM, Sun H. 1998. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Natl Acad. Sci. USA 95:15406-15411.
31. Li F, Omori N, Jin G, Wang SJ, Sato K, Nagano I, Shoji M, Abe K. 2003a. Cooperative expression of survival p-ERK and p-Akt signals in rat brain neurons after transient MCAO. Brain Res 962:21-26.
32. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
33. Li L, He F, Litofsky NS, Recht LD, Ross AH. 2003b. Profiling of genes expressed by PTEN haploinsufficient neural precursor cells. Mol Cell Neurosci 24:1051-1061.
34. Li L, Liu F, Ross AH. 2003c. PTEN regulation of neural development and CNS stem cells. J Cell Biochem 88:24-28.
35. Li L, Liu FH, Salmonsen RA, Turner TK, Litofsky NS, Cristofano AD, Pandolfi PP, Jones SN, Recht LD, Ross AH. 2002. PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation. Mol Cell Neurosci 20:21-29.
36. Luukko K, Ylikorkala A, Tiainen M, Makela TP. 1999. Expression of LKB1 and PTEN tumor suppressor genes during mouse embryonic development. Mech Dev 83:187-190.
37. Maehama T, Dixon JE. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375-13378.
38. Maehama T, Dixon JE. 1999. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol 9:125-128.
39. Maehama T, Taylor GS, Dixon JE. 2001. PTEN and myotubularin: novel phosphoinositide phosphatases. Rev Biochem 70:247-279.
40. Marino S, Krimpenfort P, Leung C, van der Korput HA, Trapman J, Camenisch I, Berns A, Brandner S. 2002. PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development 129:3513-3522.
41. Meier R, Alessi DR, Cron P, Andjelkovic M, Hemmings BA. 1997. Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase B. J Biol Chem 272:30491-30497.
42. Musatov S, Roberts J, Brooks AI, Pena J, Betchen S, Pfaff DW, Kaplitt MG. 2004. Inhibition of neuronal phenotppe by PTEN in PC12 cells. Neuroscience 101:3627-3631.
43. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK. 1998. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc Natl Acad Sci USA 95:13513-13518.
44. Namura S, Zhu J, Fink K, Endres M, Srinivasan A, Tomaselli KJ, Yuan J, Moskowitz MA. 1998. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 18:3659-3668.
45. Nguyen KT, Tajmir P, Lin CH, Liadis N, Zhu XD, Eweida M, Tolasa-Karaman G, Cai F, Wang R, Kitamura T, Belsham DD, Wheeler MB, Suzuki A, Mak TW, Woo M. 2006. Essential role of Pten in body size determination and pancreatic β-cell homeostasis in vivo. Mol Cell Biol 26:4511-4518.
46. Ning K, Miller LC, Laidlaw HA, Burgess LA, Perera NM, Downes CP, Leslie NR, Ashford ML. 2006. A novel leptin signalling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic β-cells. EMBO J 25:2377-2387.
47. Ning K, Pei L, Liao MX, Liu BS, Zhang YZ, Jiang W, Mielke JG, Li L, Chen YH, El-Hayek YH, Fehlings MG, Zhang X, Liu F, Eubanks J, Wan Q. 2004. Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. J Neurosci 24:4052-4060.
48. Noshita N, Lewen A, Sugawara T, Chan PH. 2001. Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 21:1442-1450.
49. Otaegi G, Yusta-Boyo MJ, Vergaño-Vera E, Méndez-Gómez HR, Carrera AC, Abad JL, González M, de la Rosa EJ, Vicario-Abejón C, Pablo F. 2006. Modulation of the PI 3-kinase-Akt signalling pathway by IGF-I and PTEN regulates the differentiation of neural stem/precursor cells. J Cell Sci 119:2739-2748.
50. Paxinos G, Watson C. 1997. The rat brain in stereotaxic coordinates, 3th edn. Orlando, FL: Academic Press.
51. Pekarsky Y, Koval A, Hallas C, Bichi R, Tresini M, Malstrom S, Russo G, Tsichlis P, Croce CM. 2000. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci USA 97:3028-3033.
52. Perandones C, Costanzo RV, Kowaljow V, Pivetta OH, Carminatti H, Radrizzani M. 2004. Correlation between synaptogenesis and the PTEN phosphatase expression in dendrites during postnatal brain development. Mol Brain Res 128:8-19.
53. Pilarski R, Eng C. 2004. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41: 323-326.
54. Shin BC, Suzuki M, Inukai K, Anai M, Asano T, Takata K. 1998. Multiple isoforms of the regulatory subunit for phosphatidylinositol 3-kinase (PI3-kinase) are expressed in neurons in the rat brain. Biochem Biophys Res Commun 246:313-319.
55. Simpson L, Parsons R. 2001. PTEN: life as a tumor suppressor. Exp Cell Res 264:29-41.
56. Smith ML, Bendek G, Dahlgren N, Rosen I, Wieloch T, Siesjo BK. 1984. Models for studying long-term recovery following forebrain ischemia in the rat. A 2-vessel occlusion model. Acta Neurol Scand 69:385-401.
57. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39.
58. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362.
59. Stiles B, Groszer M, Wang SI, Jiao J, Wu H. 2004. PTENless means more. Dev Biol 273:175-184.
60. Stratford TR, Kelley AE. 1999. Evidence of a functional relationship between the nucleus accumbens shell and lateral hypothalamus subserving the control of feeding behavior. J Neurosci 19:11040-11048.
61. Tanriover G, Demir N, Pestereli E, Demir R, Kayisli UA. 2005. PTEN-mediated Akt activation in human neocortex during prenatal development. Histochem Cell Biol 123:393-406.
62. Willert K, Nusse R. 1998. β-Catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8:95-102.
63. Yamada KM, Araki M. 2001. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 114:2375-2382.
64. Yuan JY, Yankner BA. 2000. Apoptosis in the nervous system. Nature 407:802-809.
65. Yue Q, Groszer M, Gil JS, Berk AJ, Messing A, Wu H, Liu X. 2005. PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization. Development 132:3281-3291.